MBOT
Microbot Medical Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$1.44
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 346.0K | — | — | — | — |
| Cost of Revenue | 987.0K | — | 91.0K | 106.0K | — |
| Gross Profit | (641.0K) | — | (91.0K) | (106.0K) | — |
| Operating Expenses | |||||
| R&D Expense | 5.9M | 6.3M | 6.6M | 5.7M | 7.7M |
| SG&A Expense | 11.8M | 8.2M | 5.0M | 4.1M | 5.6M |
| General & Admin Expense | 8.1M | 8.2M | 5.0M | 4.1M | 5.6M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 213.0K | 213.0K | (91.0K) | (106.0K) | (36.0K) |
| Total Operating Expenses | 17.9M | 14.7M | 11.5M | 9.7M | 13.3M |
| Cost and Expenses | 18.9M | 14.7M | 11.6M | 9.9M | 13.3M |
| Operating Income (EBIT) | (18.5M) | (14.7M) | (11.6M) | (9.9M) | (13.3M) |
| Non-Operating | |||||
| Interest Income | 1.3M | 1.3M | 182.0K | 228.0K | 54.0K |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | 1.3M | 1.3M | 182.0K | 228.0K | 54.0K |
| Other Non-Op Income/Expense | 2.2M | 1.6M | 182.0K | (885.0K) | 113.0K |
| Non-Operating Income (excl Interest) | (2.2M) | (1.6M) | (182.0K) | 885.0K | 156.0K |
| EBT (Pre-Tax Income) | (16.3M) | (13.1M) | (11.4M) | (10.7M) | (13.2M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (16.3M) | (13.1M) | (11.4M) | (10.7M) | (13.2M) |
| Earnings from Cont. Ops | (16.3M) | (13.1M) | (11.4M) | (10.7M) | (13.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (16.3M) | (13.1M) | (11.4M) | (10.7M) | (13.2M) |
| Per Share | |||||
| Basic EPS | ($0.26) | ($0.29) | ($0.73) | ($1.05) | ($1.81) |
| Diluted EPS | ($0.26) | ($0.29) | ($0.73) | ($1.05) | ($1.81) |
| Revenue Per Share | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 67.2M | 45.8M | 15.6M | 10.2M | 7.3M |
| Diluted Shares Outstanding | 67.2M | 45.8M | 15.6M | 10.2M | 7.3M |
| Profitability Metrics | |||||
| EBITDA | (16.3M) | (13.1M) | (11.4M) | (10.6M) | (13.3M) |
| D&A | 59.0K | 47.0K | 91.0K | 106.0K | 102.0K |
| EBIT | (16.3M) | (13.1M) | (11.4M) | (10.7M) | (13.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026